<s> Three leading drug companies reported robust third-quarter earnings , bolstered by strong sales of newer , big-selling prescriptions drugs that provide hefty profit margins . </s>
<s> Merck & Co. reported a 25 % increase in earnings ; Warner-Lambert Co. 's profit rose 22 % and Eli Lilly & Co. 's net income rose 24 % . </s>
<s> The results were in line with analysts ' expectations . </s>
<s> Merck & Co . </s>
<s> Merck , Rahway , N.J. , continued to lead the industry with a strong sales performance in the human and animal health-products segment . </s>
<s> A stronger U.S. dollar reduced third-quarter and first-nine-month sales growth 2 % and 3 % , respectively . </s>
<s> International sales accounted for 47 % of total company sales for the nine months , compared with 50 % a year earlier . </s>
<s> Sales for the quarter rose to $ 1.63 billion from $ 1.47 billion . </s>
<s> Mevacor , Merck 's new cholesterol-lowering drug , had higher sales than any other prescription medicine has ever achieved in the U.S. in the year following introduction , the company said . </s>
<s> The drug was introduced in West Germany this year . </s>
<s> Intense competition , however , led to unit sales declines for a group of Merck 's established human and animal-health products , including Aldomet and Indocin . </s>
<s> In New York Stock Exchange composite trading yesterday , Merck shares closed at $ 75.25 , up 50 cents . </s>
<s> Warner-Lambert Co . </s>
<s> Warner-Lambert , Morris Plains , N.J. , reported sales that were a record for any quarter and the eighth quarter in a row of 20 % or more per-share earnings growth . </s>
<s> Spurred by growth in world-wide sales of the company 's prescription drugs , Warner-Lambert said 1989 will be the best year in its history , with per-share earnings expected to increase more than 20 % to about $ 6.10 . </s>
<s> Sales for the quarter rose to $ 1.11 billion from $ 1.03 billion . </s>
<s> Prescription-drug world-wide sales rose 9 % in the quarter to $ 340 million ; U.S. sales rose 15 % . </s>
<s> The segment 's growth was led by sales of the cardiovascular drugs Lopid , a lipid regulator , and Dilzem , a calcium channel blocker . </s>
<s> World-wide sales of Warner-Lambert 's non-prescription health-care products , such as Halls cough tablets , Rolaids antacid , and Lubriderm skin lotion , increased 3 % to $ 362 million in the third quarter ; U.S. sales rose 5 % . </s>
<s> Confectionery products sales also had strong growth in the quarter . </s>
<s> World-wide sales of Trident gum , Certs breath mints , and Clorets gum and breath mints , increased 12 % to $ 277 million . </s>
<s> Warner-Lambert shares closed at $ 109.50 a share , up $ 1.50 , in Big Board composite trading yesterday . </s>
<s> Eli Lilly & Co . </s>
<s> Lilly attributed record third-quarter and nine-month results to world-wide gains for pharmaceuticals , medical instruments and plant-science products despite poor exchange rates for the dollar that slowed sales abroad . </s>
<s> Earnings continued to pace sales because of a lower tax rate , profit from the renegotiation of the debt instrument received from Faberge Inc. in connection with Lilly 's sale of Elizabeth Arden Inc. in 1987 , and net proceeds from the settlement of patent litigation at Lilly 's Hybritech Inc. unit . </s>
<s> Third-quarter sales of the Indianapolis , Ind. , company rose 11 % to $ 1.045 billion from $ 940.6 million . </s>
<s> Nine-month sales grew 12 % to $ 3.39 billion from $ 3.03 billion a year earlier . </s>
<s> Sales of Prozac , an anti-depressant , led drug-sales increases . </s>
<s> Higher sales of pesticides and other plant-science products more than offset a slight decline in the sales of animal-health products to fuel the increase in world-wide agricultural product sales , Lilly said . </s>
<s> Advanced Cardiovascular Systems Inc. and Cardiac Pacemakers Inc. units led growth in the medical-instrument systems division . </s>
<s> Lilly shares closed yesterday in composite trading on the Big Board at $ 62.25 , down 12.5 cents . </s>
